Offset of ticagrelor prior to coronary artery bypass graft surgery for acute coronary syndromes: effects on platelet function and cellular adenosine uptake

Offset of ticagrelor prior to coronary artery bypass graft surgery for acute coronary syndromes: effects on platelet function and cellular adenosine uptake

Ticagrelor is an antagonist of both platelet adenosine diphosphate (ADP) receptor P2Y12 and equilibrative nucleoside transporter-1. Optimal timing of ticagrelor cessation prior to coronary artery bypass grafting (CABG) remains unclear. We characterized the offset of ticagrelor’s effects on platelets...

Full description

Bibliographic Details
Main Authors: Kok Weng Ow, William A.E. Parker, Mark M. Porter, Jessica Hanson, Heather M. Judge, Norman P. Briffa, Mark R. Thomas, Robert F. Storey
Format: Article
Language:English
Published: Taylor & Francis Group 2020-10-01
Series:Platelets
Subjects:
acute coronary syndrome
adenosine
coronary artery bypass graft surgery
platelets
ticagrelor
Online Access:http://dx.doi.org/10.1080/09537104.2019.1709631

Internet

http://dx.doi.org/10.1080/09537104.2019.1709631

Similar Items